Literature DB >> 9096600

Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine.

C Peralta1, G Hotter, D Closa, E Gelpí, O Bulbena, J Roselló-Catafau.   

Abstract

The effects of ischemic preconditioning on rat liver integrity, as well as the implication of nitric oxide (NO) and adenosine in this process, has been evaluated. Preconditioning before ischemia-reperfusion prevented the increases in alanine transaminase (ALT), aspartate transaminase (AST), and lactate dehydrogenase (LDH) levels, but did not modify blood flow. Adenosine or NO administration previous to hepatic ischemia-reperfusion simulated the effect of preconditioning, whereas inhibition of adenosine or NO synthesis abolished the protective effect of hepatic preconditioning. Nevertheless, inhibition of adenosine and simultaneous administration of NO in preconditioned animals offered similar results to those found in the preconditioned group, indicating that, in the absence of adenosine, NO is able to maintain the preconditioning benefits. It is suggested that, in preconditioning, adenosine stimulates NO production to protect against the injury associated with ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096600     DOI: 10.1002/hep.510250424

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  67 in total

1.  Preconditioning for protection from ischemic injury: discriminating cause from effect from epiphenomenon.

Authors:  G B Bulkley
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

Review 2.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

3.  Preconditioning protects against ischemia/reperfusion injury of the liver.

Authors:  B Nilsson; S Friman; B I Gustafsson; D S Delbro
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

Review 4.  Molecular mechanisms of liver preconditioning.

Authors:  Elisa Alchera; Caterina Dal Ponte; Chiara Imarisio; Emanuele Albano; Rita Carini
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 5.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

6.  Protection of Veratrum nigrum L. var. ussuriense Nakai alkaloids against ischemia-reperfusion injury of the rat liver.

Authors:  Zhen-Zhen Wang; Wei-Jie Zhao; Xue-Song Zhang; Xiao-Feng Tian; Yu-Zhu Wang; Feng Zhang; Jin-Chan Yuan; Guo-Zhu Han; Ke-Xin Liu; Ji-Hong Yao
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

7.  Endothelin mediated nitric oxide effects in ischemia--reperfusion associated with pancreas transplantation.

Authors:  G Hotter; F Pi; C Sanz; C Peralta; N Prats; E Gelpi; F Badosa; L Fernández-Cruz; J Roselló-Catafau
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

8.  SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

Authors:  Melanie L Hart; Iris C Gorzolla; Jens Schittenhelm; Simon C Robson; Holger K Eltzschig
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

9.  Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat.

Authors:  Anna Serafín; Joan Roselló-Catafau; Neus Prats; Carme Xaus; Emilio Gelpí; Carmen Peralta
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

10.  Ischemic preconditioning decreases C-X-C chemokine expression and neutrophil accumulation early after liver transplantation in rats.

Authors:  Yong Jiang; Xiao-Ping Gu; Yu-Dong Qiu; Xue-Mei Sun; Lei-Lei Chen; Li-Hua Zhang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.